ENGINEERING BIOLOGY RESEARCH CONSORTIUM (EIN 812614456) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2016

Legal Domicile

Principal Officer

INDIA HOOK-BARNARD

Phone

5108713272

Tax Period

2022-07-01 to 2023-06-30

ENGINEERING BIOLOGY RESEARCH CONSORTIUM, founded in 2016, is a small nonprofit in the Science & Technology sector that reported $143K in total revenue in fiscal year 2022. Revenue fell 98% from the prior year — a significant decline worth monitoring. Expenses of $7.1M exceeded revenue, resulting in a 4850% operating deficit.

Mission

TO SUPPORT AND PROMOTE THE VISION AND GOALS OF THE SYNTHETIC BIOLOGY COMMUNITY BY PROVIDING THE FUTURE VISION FOR SYNTHETIC BIOLOGY, BRINGING TOGETHER INDUSTRIAL AND SCIENTIFIC COMMUNITIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $124,667

Program Service Revenue $18,413

Investment Income $0

Other Revenue $0

TOTAL REVENUE $143,080

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $79,086

Other Expenses $7,082,588

TOTAL EXPENSES $7,082,588

Year-over-Year Comparison

	2022	2021	Change
Revenue	$143,080	$7,327,894	-1.0%
Expenses	$7,082,588	$232,093	+29.5%
Net Income	$-6,939,508	$7,095,801	-2.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

120

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$521,770

Total Directors

$458,359

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
REBECCA NUGENT	DIRECTOR	1.00	Director	$0	$0	$0
MATRIEYA DUNHAM	DIRECTOR	1.00	Director	$0	$0	$0
JOSH LEONARD	DIRECTOR	1.00	Director	$0	$0	$0
LAUREN JUNKER	DIRECTOR	1.00	Director	$0	$0	$0
DOUGLAS FRIEDMAN	PRESIDENT	10.00	Officer Director	$0	$32,367	$458,359
DIANE PIEROTTI	SECRETARY, TREASURER/CFOO	3.00	Officer	$0	$3,287	$63,411
INDIA HOOK-BARNARD	VICE PRESIDENT & EXECUTIVE	10.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$143,080	$7,082,588	$373,316	$-6,939,508
2022	$7,327,894	$232,093	$7,364,637	$7,095,801
2021	$251,299	$142,920	$261,794	$108,379
2020	$272,849	$184,580	$153,736	$88,269
2019	$141,440	$127,680	$93,142	$13,760
2018	$171,750	$33,075	$79,717	$138,675

ENGINEERING BIOLOGY RESEARCH CONSORTIUM